BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22503060)

  • 21. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of multifocal motor neuropathy (Lewis-Sumner)].
    Kaji R
    Rinsho Shinkeigaku; 1999 Jan; 39(1):107-9. PubMed ID: 10377829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies.
    O'Ferrall EK; White CM; Zochodne DW
    Muscle Nerve; 2010 Oct; 42(4):604-8. PubMed ID: 20730877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
    Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
    Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor neuropathies and antiglycolipid antibodies.
    Serratrice G
    Clin Exp Neurol; 1993; 30():25-32. PubMed ID: 7712626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Criteria for electrographic methodology in the diagnosis of subclinical neuropathy (review)].
    Zampollo A
    Riv Neurobiol; 1983; 29(1):5-25. PubMed ID: 6320350
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlation of clinical and demyelinating features in patients with neuropathy of otherwise unknown etiology.
    Goldfarb AR; Latov N; Brannagan TH; Chin RL; de Sousa EA; Sander HW
    Neurol Neurophysiol Neurosci; 2006 Dec; ():7. PubMed ID: 17260084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropathy in childhood.
    Sladky JT
    Semin Neurol; 1987 Mar; 7(1):67-75. PubMed ID: 2845547
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the mechanisms and diagnosis of conduction disturbances due to demyelination with special reference to multifocal demyelinating neuropathy (Lewis-Sumner)].
    Kaji R; Kimura J
    Rinsho Shinkeigaku; 1991 Dec; 31(12):1330-2. PubMed ID: 1817801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
    Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
    Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifocal motor neuropathy with conduction block: current issues in diagnosis and treatment.
    Nagale SV; Bosch EP
    Semin Neurol; 2003 Sep; 23(3):325-34. PubMed ID: 14722828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of chronic inflammatory demyelinating polyneuropathy with recurrent ophthalmoplegia, persistent conduction block, antibody activity against gangliosides GM1].
    Ryo M; Saito T; Kunii N; Hasegawa H; Kowa H
    Rinsho Shinkeigaku; 1994 Jul; 34(7):702-6. PubMed ID: 7955728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute motor conduction block neuropathy: Another Guillain-Barré syndrome variant.
    Berciano J; García A
    Neurology; 2004 Mar; 62(6):1026-7. PubMed ID: 15037724
    [No Abstract]   [Full Text] [Related]  

  • 35. In response to "Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies".
    Caliandro P; Stålberg E; Padua L
    Clin Neurophysiol; 2008 Jul; 119(7):1694-5. PubMed ID: 18467169
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The F wave disappears due to impaired excitability of motor neurons or proximal axons in inflammatory demyelinating neuropathies.
    Yokota T; Inaba A; Yuki N; Ichikawa T; Tanaka H; Saito Y; Kanouchi T
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):650-4. PubMed ID: 8648332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed motor and sensory neuropathy in a patient with brainstem encephalitis.
    Chikakiyo H; Kunishige M; Yoshino H; Asano A; Sumitomo Y; Endo I; Matsumoto T; Mitsui T
    J Neurol Sci; 2005 Jul; 234(1-2):105-8. PubMed ID: 15936038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.